MOUWASAT

Mouwasat Medical Services Co.

4002StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	12.60B	14.53B	13.33B	14.73B	15.09B
Market Cap Growth	-13.1%	-3.1%	-21.7%	-26.3%	-37.7%
Enterprise Value	13.41B	15.16B	13.97B	15.49B	15.34B
Last Close Price	63.00	71.45	65.55	71.40	73.15
Valuation Multiples
Forward PE (Next 12M Est.)	14.54	17.41	16.67	19.16	20.74
PE Ratio	15.25	17.59	16.22	19.50	21.39
PEG Ratio	2.91	1.49	1.49	1.49	1.49
PS Ratio	3.83	4.41	4.14	4.76	4.99
PB Ratio	3.05	3.52	3.40	3.78	4.09
P/TBV Ratio	3.20	3.70	3.57	3.97	4.30
P/FCF Ratio	18.22	21.01	17.36	20.47	—
P/OCF Ratio	10.35	11.93	11.32	11.69	14.29
EV/Sales Ratio	4.07	4.61	4.34	5.01	5.07
EV/EBITDA Ratio	11.94	13.54	12.51	14.72	15.24
EV/EBIT Ratio	15.37	17.38	15.90	19.05	19.96
EV/FCF Ratio	19.40	21.93	18.19	21.54	—
Leverage & Capital
Debt / Equity Ratio	0.28	0.28	0.25	0.27	0.26
Debt / EBITDA Ratio	1.03	1.04	0.81	0.97	0.90
Debt / FCF Ratio	1.67	1.67	1.29	1.48	—
Net Debt / Equity Ratio	0.16	0.16	0.13	0.13	0.17
Net Debt / EBITDA Ratio	0.59	0.59	0.44	0.47	0.62
Net Debt / FCF Ratio	0.96	0.96	0.64	0.68	1.00
Efficiency & Liquidity
Asset Turnover	0.53	0.60	0.54	0.57	0.55
Inventory Turnover	7.67	8.03	9.33	7.05	6.80
Quick Ratio	1.30	1.30	1.41	1.58	1.52
Current Ratio	1.62	1.62	1.74	1.98	1.95
Returns & Yields
Return on Equity (ROE)	+20.8%	+25.1%	+21.8%	+20.5%	+21.4%
Return on Assets (ROA)	+8.3%	+10.5%	+9.3%	+9.1%	+9.7%
Return on Invested Capital (ROIC)	+4.5%	+5.5%	+4.8%	+4.7%	+5.1%
Return on Capital Employed (ROCE)	+16.2%	+16.2%	+17.6%	+16.2%	+16.4%
Earnings Yield	+6.6%	+5.7%	+6.2%	+5.1%	+4.7%
FCF Yield	+5.5%	+4.8%	+5.8%	+4.9%	+4.2%
Dividend Yield	+3.6%	—	+3.2%	—	+4.1%
Payout Ratio	+72.6%	—	+83.9%	—	+213.9%
Buyback Yield / Dilution	—	—	—	—	-0.1%
Total Shareholder Return	+3.6%	—	+3.2%	—	+4.0%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	Q1 2026Mar 31, 2026	Q4 2025Dec 31, 2025	Q3 2025Sep 30, 2025	Q2 2025Jun 30, 2025
Market & Price
Market Capitalization	12.60B	14.53B	13.33B	14.73B	15.09B
Market Cap Growth	-13.1%	-3.1%	-21.7%	-26.3%	-37.7%
Enterprise Value	13.41B	15.16B	13.97B	15.49B	15.34B
Last Close Price	63.00	71.45	65.55	71.40	73.15
Valuation Multiples
Forward PE (Next 12M Est.)	14.54	17.41	16.67	19.16	20.74
PE Ratio	15.25	17.59	16.22	19.50	21.39
PEG Ratio	2.91	1.49	1.49	1.49	1.49
PS Ratio	3.83	4.41	4.14	4.76	4.99
PB Ratio	3.05	3.52	3.40	3.78	4.09
P/TBV Ratio	3.20	3.70	3.57	3.97	4.30
P/FCF Ratio	18.22	21.01	17.36	20.47	—
P/OCF Ratio	10.35	11.93	11.32	11.69	14.29
EV/Sales Ratio	4.07	4.61	4.34	5.01	5.07
EV/EBITDA Ratio	11.94	13.54	12.51	14.72	15.24
EV/EBIT Ratio	15.37	17.38	15.90	19.05	19.96
EV/FCF Ratio	19.40	21.93	18.19	21.54	—
Leverage & Capital
Debt / Equity Ratio	0.28	0.28	0.25	0.27	0.26
Debt / EBITDA Ratio	1.03	1.04	0.81	0.97	0.90
Debt / FCF Ratio	1.67	1.67	1.29	1.48	—
Net Debt / Equity Ratio	0.16	0.16	0.13	0.13	0.17
Net Debt / EBITDA Ratio	0.59	0.59	0.44	0.47	0.62
Net Debt / FCF Ratio	0.96	0.96	0.64	0.68	1.00
Efficiency & Liquidity
Asset Turnover	0.53	0.60	0.54	0.57	0.55
Inventory Turnover	7.67	8.03	9.33	7.05	6.80
Quick Ratio	1.30	1.30	1.41	1.58	1.52
Current Ratio	1.62	1.62	1.74	1.98	1.95
Returns & Yields
Return on Equity (ROE)	+20.8%	+25.1%	+21.8%	+20.5%	+21.4%
Return on Assets (ROA)	+8.3%	+10.5%	+9.3%	+9.1%	+9.7%
Return on Invested Capital (ROIC)	+4.5%	+5.5%	+4.8%	+4.7%	+5.1%
Return on Capital Employed (ROCE)	+16.2%	+16.2%	+17.6%	+16.2%	+16.4%
Earnings Yield	+6.6%	+5.7%	+6.2%	+5.1%	+4.7%
FCF Yield	+5.5%	+4.8%	+5.8%	+4.9%	+4.2%
Dividend Yield	+3.6%	—	+3.2%	—	+4.1%
Payout Ratio	+72.6%	—	+83.9%	—	+213.9%
Buyback Yield / Dilution	—	—	—	—	-0.1%
Total Shareholder Return	+3.6%	—	+3.2%	—	+4.0%